Swiss National Bank
IMGN

Swiss National Bank’s Immunogen Inc IMGN Stock Holding History

Swiss National Bank’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-480,800
Closed -$14.3M – 2550
2023
Q4 		$14.3M Hold
480,800
– – 0.01% 728
2023
Q3 		$7.63M Buy
480,800
+4,700
+1% +$78.2K 0.01% 1030
2023
Q2 		$8.98M Buy
476,100
+47,300
+11% +$558K 0.01% 972
2023
Q1 		$1.65M Sell
428,800
-50,800
-11% -$217K ﹤0.01% 1957
2022
Q4 		$2.38M Buy
479,600
+8,900
+2% +$48.3K ﹤0.01% 1781
2022
Q3 		$2.25M Buy
470,700
+3,200
+0.7% +$16.9K ﹤0.01% 1794
2022
Q2 		$2.1M Sell
467,500
-11,600
-2% -$50.4K ﹤0.01% 1876
2022
Q1 		$2.28M Buy
479,100
+33,800
+8% +$187K ﹤0.01% 1957
2021
Q4 		$3.3M Buy
445,300
+3,500
+0.8% +$21.8K ﹤0.01% 1730
2021
Q3 		$2.5M Buy
441,800
+13,400
+3% +$77.4K ﹤0.01% 1903
2021
Q2 		$2.82M Hold
428,400
– – ﹤0.01% 1872
2021
Q1 		$3.47M Buy
428,400
+33,100
+8% +$270K ﹤0.01% 1679
2020
Q4 		$2.55M Hold
395,300
– – ﹤0.01% 1772
2020
Q3 		$1.42M Buy
395,300
+8,700
+2% +$35.1K ﹤0.01% 1893
2020
Q2 		$1.78M Buy
386,600
+54,900
+17% +$233K ﹤0.01% 1780
2020
Q1 		$1.13M Buy
331,700
+44,800
+16% +$196K ﹤0.01% 1755
2019
Q4 		$1.47M Buy
286,900
+6,300
+2% +$21.4K ﹤0.01% 1913
2019
Q3 		$679K Buy
280,600
+8,900
+3% +$23.6K ﹤0.01% 2248
2019
Q2 		$590K Hold
271,700
– – ﹤0.01% 2362
2019
Q1 		$736K Buy
271,700
+8,200
+3% +$35.5K ﹤0.01% 2236
2018
Q4 		$1.26M Buy
263,500
+9,500
+4% +$57.6K ﹤0.01% 1852
2018
Q3 		$2.4M Hold
254,000
– – ﹤0.01% 1606
2018
Q2 		$2.47M Buy
254,000
+35,400
+16% +$373K ﹤0.01% 1561
2018
Q1 		$2.3M Buy
218,600
+57,400
+36% +$567K ﹤0.01% 1542
2017
Q4 		$1.03M Buy
161,200
+23,000
+17% +$142K ﹤0.01% 2082
2017
Q3 		$1.06M Hold
138,200
– – ﹤0.01% 2031
2017
Q2 		$983K Sell
138,200
-21,200
-13% -$97K ﹤0.01% 2067
2017
Q1 		$617K Hold
159,400
– – ﹤0.01% 2287
2016
Q4 		$325K Hold
159,400
– – ﹤0.01% 2505
2016
Q3 		$427K Hold
159,400
– – ﹤0.01% 2399
2016
Q2 		$491K Buy
159,400
+3,300
+2% +$20.7K ﹤0.01% 2362
2016
Q1 		$1.29M Buy
156,100
+26,400
+20% +$223K ﹤0.01% 1746
2015
Q4 		$1.76M Hold
129,700
– – ﹤0.01% 1430
2015
Q3 		$1.25M Buy
129,700
+14,500
+13% +$212K ﹤0.01% 1623
2015
Q2 		$1.66M Sell
115,200
-7,000
-6% -$76.9K ﹤0.01% 1437
2015
Q1 		$1.09M Buy
122,200
+26,000
+27% +$188K ﹤0.01% 1719
2014
Q4 		$587K Buy
96,200
+2,000
+2% +$18.3K ﹤0.01% 2083
2014
Q3 		$998K Sell
94,200
-1,600
-2% -$18.1K ﹤0.01% 1670
2014
Q2 		$1.14M Hold
95,800
– – ﹤0.01% 1643
2014
Q1 		$1.43M Buy
95,800
+22,100
+30% +$348K 0.01% 1460
2013
Q4 		$1.08M Hold
73,700
– – ﹤0.01% 1452
2013
Q3 		$1.25M Sell
73,700
-3,800
-5% -$66.8K 0.01% 1284
2013
Q2 		$1.29M Buy
+77,500
New +$1.26M 0.01% 1247

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Swiss National Bank's IMGN Position: Q1 2024 in Review

Swiss National Bank sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 480,800 shares — an estimated $14.3M sold.

Swiss National Bank first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $14.3M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Swiss National Bank reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Swiss National Bank sold 480,800 Immunogen Inc shares in Q1 2024, an estimated $14.3M.
  • Swiss National Bank first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • Swiss National Bank's Immunogen Inc position peaked at $14.3M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Swiss National Bank's 13F filing for Q1 2024, filed 7 May 2024.